Maryland Subject | Pharmacy Benefits Managers | House

Type

Status

State	Bill	Status	Summary/Title	Last Action
MD	HB932	Enroll 75%	Altering and establishing requirements and prohibitions related to health insurance utilization review; altering requirements related to internal grievance procedures and adverse decision procedures; altering certain reporting requirements on health ... [Detail][Text][Discuss]	2024-04-05 Passed Enrolled
MD	HB876	Engross 50%	Prohibiting certain insurers, nonprofit health service plans, and health maintenance organizations from excluding coverage for certain specialty drugs that are administered or dispensed by a provider that meets certain criteria; and requiring the rei... [Detail][Text][Discuss]	2024-03-18 To Senate Finance Committee
MD	HB1270	Intro 25%	Requiring that the calculation of an enrollee's contribution to a cost sharing requirement for a prescription drug be based on the list price of the drug reduced by at least 85% of the total amount of rebates received or expected to be received by th... [Detail][Text][Discuss]	2024-03-16 Withdrawn by Sponsor
MD	HB726	Engross 50%	Altering the definition of "purchaser" for the purpose of certain provisions of State insurance law governing pharmacy benefits managers to exclude certain nonprofit health maintenance organizations; and repealing certain provisions that restrict app... [Detail][Text][Discuss]	2024-03-14 To Senate Finance Committee
MD	HB879	Engross 50%	Requiring certain insurers, nonprofit health service plans, and health maintenance organizations to include certain discounts, financial assistance payments, product vouchers, and other out-of-pocket expenses made by or on behalf of an insured or enr... [Detail][Text][Discuss]	2024-03-14 To Senate Finance Committee
MD	HB736	Intro 25%	Requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, and health maintenance organizations to cover nonprescription naloxone hydrochloride and any other drug or product that is approved by the federal... [Detail][Text][Discuss]	2024-02-26 Withdrawn by Sponsor
MD	HB880	Intro 25%	Altering the reimbursement levels for drug products that the Maryland Medical Assistance Program is required to establish and that pharmacy benefits managers that contract with a pharmacy on behalf of a managed care organization are required to reimb... [Detail][Text][Discuss]	2024-02-09 To House Health and Government Operations Committee
MD	HB1368	Intro 25%	Prohibiting certain health insurance entities from taking certain actions with respect to the dispensing of clinician-administered drugs and related services; and authorizing certain health insurance entities to allow the use of a certain pharmacy or... [Detail][Text][Discuss]	2024-02-09 To House Health and Government Operations Committee